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JAM van Eekelen3, Trevor A Mori1, Leon A Adams1,3 and Jeffrey M Craig6Abstract
Background: The insulin-like growth factor 2 (IGF2) and H19 imprinted genes control growth and body
composition. Adverse in-utero environments have been associated with obesity-related diseases and linked with
altered DNA methylation at the IGF2/H19 locus. Postnatally, methylation at the IGF2/H19 imprinting control region
(ICR) has been linked with cerebellum weight. We aimed to investigate whether decreased IGF2/H19 ICR
methylation is associated with decreased birth and childhood anthropometry and increased contemporaneous
adiposity.
DNA methylation in peripheral blood (n = 315) at 17 years old was measured at 12 cytosine-phosphate-guanine
sites (CpGs), analysed as Sequenom MassARRAY EpiTYPER units within the IGF2/H19 ICR. Birth size, childhood head
circumference (HC) at six time-points and anthropometry at age 17 years were measured. DNA methylation was
investigated for its association with anthropometry using linear regression.
Results: The principal component of IGF2/H19 ICR DNA methylation (representing mean methylation across all CpG
units) positively correlated with skin fold thickness (at four CpG units) (P-values between 0.04 to 0.001) and
subcutaneous adiposity (P = 0.023) at age 17, but not with weight, height, BMI, waist circumference or visceral
adiposity. IGF2/H19 methylation did not associate with birth weight, length or HC, but CpG unit 13 to 14
methylation was negatively associated with HC between 1 and 10 years. β-coefficients of four out of five remaining
CpG units also estimated lower methylation with increasing childhood HC.
Conclusions: As greater IGF2/H19 methylation was associated with greater subcutaneous fat measures, but not
overall, visceral or central adiposity, we hypothesize that obesogenic pressures in youth result in excess fat being
preferentially stored in peripheral fat depots via the IGF2/H19 domain. Secondly, as IGF2/H19 methylation was not
associated with birth size but negatively with early childhood HC, we hypothesize that the HC may be a more
sensitive marker of early life programming of the IGF axis and of fetal physiology than birth size. To verify this,
investigations of the dynamics of IGF2/H19 methylation and expression from birth to adolescence are required.
Keywords: Childhood, Fetal programming, DNA methylation, Insulin-like growth factor, Raine Study, Head
circumference* Correspondence: rae-chi.huang@uwa.edu.au
1School of Medicine and Pharmacology, University of Western Australia
(UWA), Perth, WA, Australia
2School of Paediatrics and Child Health Research, (UWA), Perth, WA, Australia
Full list of author information is available at the end of the article
© 2012 Huang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Huang et al. Clinical Epigenetics 2012, 4:21 Page 2 of 11
http://www.clinicalepigeneticsjournal.com/content/4/1/21Background
Insulin-like growth factor 2 (IGF2) is one of two ligands
within the IGF axis central to the control of somatic
growth, especially in early life, through a balance of cell
proliferation and apoptosis. IGF2’s major signal transduc-
tion is via activation of the IGF1 receptor, which mediates
anabolic effects in adults. Activation of this receptor has
systemic growth promoting effects, particularly on skeletal
muscle, bone and neural tissue [1]. A critical timing of ac-
tion of IGF2 appears to be antenatal, with Igf2-deficient
mice being severely growth restricted at delivery [2,3].
IGF2 also acts as part of the IGF signaling pathway to
regulate the postnatal growth of somatic tissues, including
the brain [4] and, later in life, changes in the IGF axis
manifest in altered fat and body composition. Decreased
expression of Igf2 is associated with increased fat mass,
despite hypophagia, in a mouse model [5]. In adult
humans, lower circulating IGF2 levels have been asso-
ciated with increased risk of weight gain and obesity [6].
Furthermore, associations have been found between IGF2
genotype and obesity in humans in some studies [7-12] or
with height but not obesity [13].
The IGF2/H19 locus is involved in fetal programming
through DNA methylation in rodents [14] and humans
[15]. It is perhaps the best studied of all identified
imprinted genetic loci [16]. In imprinting, genes are
expressed in a parent-of-origin manner, under the control
of imprinting control regions (ICRs), which are themselves
differentially methylated between maternal and paternal
alleles [17]. In humans, the IGF2 gene and adjacent H19
non-coding RNA are clustered in an imprinted region on
the short arm of chromosome 11. The cluster is regulated
by an ICR, which contains multiple binding sites for the
insulator protein CTCF, the critical site referred to as
CTCF6 [18]. An unmethylated IGF2/H19 ICR on the ma-
ternal allele allows binding of CTCF which blocks tran-
scription of IGF2 and activates H19, in turn inhibiting
growth. Conversely, on the paternal allele, IGF2/H19 ICR
methylation activates IGF2 transcription and silences H19.
In general, H19 has a growth restraining effect and IGF2,
a growth promoting effect. Accurate DNA methylation of
the IGF2/H19 locus is important for growth [19] and dis-
orders of imprinting mediated by DNA methylation in this
region (Russell Silver and Beckwith Wiedemann syn-
dromes) are associated with clear phenotypes of altered
growth [20,21]. Russell Silver Syndrome is usually asso-
ciated with hypomethylation of the ICR, which may lead
to a tissue specific loss of IGF2 gene activity and increased
activity of the H19 gene [22]. The overgrowth Beckwith-
Wiedemann syndrome is associated with hypermethyla-
tion of the ICR, leading to increase of IGF2 and decrease
in H19 activity.
Adverse intrauterine events have been associated with
subsequent obesity and metabolic disease in so-called“fetal programming” [23], but the underlying mechanisms
for this are not well understood. One major candidate is
epigenetic dysregulation, of which DNA methylation is the
most studied mechanism, and which has been shown to
have a role in animal models of fetal programming
[24,25]. For example, a recent study showed that a mater-
nal low protein diet during gestation in rats resulted in
greater DNA methylation of the IGF2/H19 ICR in liver tis-
sue, which interestingly was reversed with the addition of
folate to the maternal diet [14].
The first empirical evidence in a human population
confirming that altered DNA methylation is associated
with fetal programming was shown elsewhere within the
IGF2/H19 locus. Offspring exposed to maternal starva-
tion early in gestation during the Dutch Famine in the
1940s had decreased methylation at the IGF2 DMR, an
imprinted region of differential methylation within the
IGF2 gene [15] which was accompanied by obesity later
in life [26,27]. In addition, periconceptional folic acid
supplementation has also been associated with increased
DNA methylation levels at the IGF2 DMR (upstream of
exon 3) [28]. Such supplementation has also been asso-
ciated with decreased methylation at the ICR region
CTCF6 [29] that has been linked to overweight status at
age one year [30]. We hypothesize that this overweight
status may persist to age 17 years.
In the present study, our aim was to investigate
whether at 17 years of age increased methylation of the
ICR of the IGF2/H19 locus is associated with greater
adiposity (BMI, abdominal and visceral adiposity) and
decreased subcutaneous fat, and whether decreased earl-
ier measures of anthropometry from birth onwards are
associated with increased IGF2/H19 ICR methylation.Results
General characteristics
General characteristics of the 17-year-old participants
used in the current study are shown in Table 1. Of the 315
participants derived from this population cohort, none
were diagnosed with pre-existing type 1 or 2 diabetes, the
metabolic syndrome [31] or Beckwith-Wiedemann Syn-
drome. A comparison with all 17-year-old Raine study
participants is shown in Additional file 1: Table S1. Those
with DNA methylation measured showed minor differ-
ences, being younger by 2.5 months and having on average
a greater BMI of 0.8 kg/m2. There was no difference with
respect to gestational age at delivery, gender or birth
weight. Figure 1 shows the amount of DNA methylation
for each of the 6 IGF2/H19 ICR CpG units investigated
separated by sex. DNA methylation ranged between 30 to
70%, and there was no significant difference in the amount
of DNA methylation at this locus in males and females (all
P >0.05).
Table 1 General characteristics of the individuals at age 17 years for which DNA methylation was measured
Male Female
n 162 144
Mean (SD) Mean (SD)
Age (years) 16.4 (0.5) 16.4 (0.5)
Weight (kg) 59.4 (14.8) 58.6 (14.7)
Height (cm) 166.7 (8.4) 162.6 (6.2)
BMI (kg/m2) 21.2 (4.5) 22.1 (5.1)
Waist circumference (cm) 77.6 (12.6) 75.7 (12.0)
Gestational age (weeks) 39.0 (1.7) 39.0 (1.6)
% %
Family income (%)
≤$25,000 4.6 8.6
$25,000 to $50,000 13.8 24.2
$50,001 to $104,000 41.5 43.8
≥$104,001 36.2 23.4
Ethnicity (% whose mothers are Caucasian) 91 88
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We measured DNA methylation at the IGF2/H19 ICR in
peripheral blood from the 315 17-year-old participants
using the Sequenom MassARRAY EpiTYPER platform,
which is based on bisulphite conversion of only non-
methylated cytosines to uracil, base-specific cleavage (in
this case, at the thymine base) and mass spectrometry.
This produced quantitative methylation data for 12
CpGs clustered into 6 CpG units (Figure 1), correspond-
ing to quantifiable fragments each containing 1 to 4
CpGs. No association was seen between IGF2/H19 ICR
DNA methylation at age 17 years and birth weight, birth0
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Figure 1 Percentage DNA methylation of each CpG unit of the ICR of
bars. Error bars show standard deviation.length or birth head circumference (all P >0.05). (Add-
itional file 1: Tables S2 and S3).
Association between IGF2/H19 ICR DNA methylation and
anthropometry at age 17
All further results are presented in units of sex-specific z-
scores to simplify models such that gender need not be
included in the models, since anthropometry differed by
sex. To allow conversion of measures of association into
original units, Table 2 gives the sex-specific standard devia-
tions for each of the measurements at 17 years (a one unit
change in z-score for a given variable corresponds to a oneMales
Females
 Site
-14 21-22 23
the IGF2/H19 locus. Males are shown in shaded and females in open
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able). Results from univariate regression analysis of the as-
sociation between IGF2/H19 ICR methylation at each CpG
unit and anthropometric measurements are shown in Add-
itional file 1: Table S2.
Figure 2 shows the association between principal compo-
nents 1 (representing the mean of methylation across the
CpG units) and 2 (representing the within-subject standard
deviation) of IGF2/H19 methylation with anthropometric
measurements at age 17 years. No relationship was seen
between DNA methylation and weight, height and BMI or
waist circumference. A positive association was seen
between principal component 1 of DNA methylation andTable 2 One standard deviation for each anthropometry
and DNA methylation variable
1 Standard deviation Males Females
Weight (kg) 14.6 13.3
Height (cm) 7.3 6.5
BMI (kg/m2) 4.2 4.6
Waist (cm) 10.9 11.4
Skin fold thickness (mm)
Subscapular 6.5 6.7
Suprailiac 8.6 7.8
Abdominal 9.7 7.9
Triceps 6.2 6.2
Fat thickness (cm)
Subcutaneous 10.5 11.1
Visceral 10.7 8.9
Birth weight (g) 621 613
Birth length (cm) 2.9 3.0
Birth head circumference (cm) 2.0 2.0
Head circumference at age 1 (cm) 1.3 1.3
Head circumference at age 2 (cm) 1.4 1.4
Head circumference at age 3 (cm) 1.4 1.4
Head circumference at age 5 (cm) 1.5 1.4
Head circumference at age 8 (cm) 1.5 1.5
Head circumference at age 10 years (cm) 1.5 1.7
Principal components
Principal component 1 (score) 1.8 1.6
Principal component 2 (score) 1.3 1.1
CpG 1 (%) 3.9 3.9
CpG 5 to 8 (%) 5.1 4.6
CpG 11 to 12 (%) 4.0 5.0
CpG 13 to 14 (%) 3.7 3.6
CpG 21 to 22 (%) 6.6 6.1
CpG 23 (%) 7.2 6.7
Mean H19 (%) 4.6 6.5
Average of all SD 5.1 5.0
A change of one in a z-score for a given variable corresponds to a one
standard deviation change in units for that variable.three measures of skin-fold thicknesses (subscapular,
suprailiac, triceps and abdominal) at age 17. A one z-score
increase in IGF2/H19 ICR DNA methylation principal com-
ponent 1 was associated with a 0.24 (95% CI 0.09 to 0.40)
standard deviations increase in abdominal skin-fold thick-
ness. This is equivalent to a change in 2.5 mm in boys and
2.0 mm in girls. Since principal component 1 reflects aver-
age methylation across the six CpG units, a one z-score in-
crease in principal component 1 corresponds to an
approximate 5.1% (males) and 5.0% (females) increase in
average DNA methylation in this locus. A positive associ-
ation was also seen between IGF2/H19 ICR DNA methyla-
tion principal component 1 and subcutaneous fat thickness,
but not with visceral fat thickness (Figure 2).
Association of IGF2/H19 ICR methylation with serial head
circumference between 1 and 10 years
Head circumference was measured at six time points be-
tween 1 and 10 yearsof age, necessitating a variance
component adjustment using STATA’s vce option, to ac-
count for the correlation between repeated measures
within a subject. On univariate regression, methylation
at two CpG units was associated with aggregated head
circumference (Table 3). One SD increase in IGF2/H19
CpG 13 to 14 was associated with a decrease in 0.12
z-score of head circumference. This equates to a 3.4%
increase in methylation at this CpG unit being asso-
ciated with a decrease in head circumference of 18 mm
(P = 0.006). Although four out of five of the remaining
CpG units also had negative coefficients, albeit not
reaching statistical significance (P = 0.089 to 0.27), nei-
ther principal component 1 nor 2 was associated with
aggregated head circumference.
Discussion
This study showed no evidence that IGF2/H19 ICR
DNA methylation in peripheral blood at age 17 years is
associated with birth anthropometry. On the other hand,
a negative association with aggregated head circumfer-
ence from 1 to 10 years and a positive association with
skin fold thicknesses from multiple sites and subcutane-
ous adiposity at 17 years were observed.
Our study found repeated positive associations of
greater IGF2/H19 ICR methylation with greater subcuta-
neous adiposity measured by multiple methods, includ-
ing direct ultrasound and by calliper assessed skin folds
at multiple body sites. The positive association of IGF2/
H19 ICR methylation with subcutaneous adiposity in
this study adds to the recent observations by Perkins
et al. showing greater IGF/H19 ICR methylation in over-
weight or obese one-year-olds compared to normal
weight counterparts [30]. The current study shows that
an association between adiposity and methylation at this
site persists to young adult life. It is also consistent with
-0.4 -0.2 0 0.2 0.4 0.6 0.8 1
Triceps
Abdominal Skin fold
Suprailiac
Subscapular
Subcutaneous Fat
Visceral Fat
Waist
Height
Weight Principle Component 1 of
IGF2/H19 DNA methylation
Principle Component 2 of
IGF2/H19 DNA methylation
**
**
**
*
*
β-Coefficient
Figure 2 Linear regression showing the effect of IGF2/H19 methylation principal components upon age 17 years anthropometry. The
β-coefficient and 95% confidence interval of the principle components of IGF2/H19 methylation are shown for a unit change in anthropometric
measure. Principal component 1 (indicated by gray shaded bars and solid confidence interval lines) reflects within subject mean of IGF2/H19
methylation. Principal component 2 (indicated by open bars and dotted confidence interval lines) reflects within-subject standard deviation of
the IGF2/H19 methylation. * indicates a P-value <0.05 and ** indicates a P-value <0.005.
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proportion of subcutaneous fat to visceral fat [32,33],
particularly in younger age groups. In neonates, levels of
IGF1 protein have been positively associated with sub-
cutaneous fat and sum of skin folds, but not with vis-
ceral fat [32]. Interestingly, Russell Silver syndrome
patients, who have decreased expression of IGF2, have a
striking lack of subcutaneous fat as part of their general-
ized growth retardation [34]. Furthermore, genome wide
association studies have identified the 11p15.5 regionTable 3 Univariate regression of head circumference on
IGF/H19 ICR
Coefficient P-value 95% CI
CpG1 −0.08 0.12 −0.17 to 0.02
CpG5-8 −0.05 0.27 −0.14 to 0.04
CpG11-12 −0.9 0.089 −0.19 to 0.01
CpG13-14 −0.12 0.006 −0.21 to −0.04
CpG21-22 −0.07 0.11 −0.16 to 0.02
CpG23 0.04 0.38 −0.05 to 0.13
Principal component 1 −0.07 0.14 −0.16 to 0.02
Principal component 2 0.07 0.17 −0.03 to 0.18
Head circumference is associated with each of the six CpG units and on
principal components 1 and 2 of DNA methylation. Within subject correlation
across time between 1 and 10 years of age was accounted for using a
sandwich estimator (vce option in STATA).inclusive of the IGF2 gene to be associated with abdom-
inal subcutaneous fat [35,36].
In general, activation of the IGF axis decreases overall
fatness. Many [7,9-12], but not all [13] candidate studies
have shown that IGF2 polymorphisms are associated with
overall fatness. Specific to visceral adiposity, some [37],
but not all [38] studies show an inverse correlation with
IGF1 protein levels. Despite this, contrary to our initial hy-
potheses, no relationships were seen between IGF2/H19
ICR methylation and either BMI, waist circumference or
visceral fat at age 17 years. BMI is relatively easy to meas-
ure, but does not always correlate with total fat mass and
may be confounded by muscle mass [39]. As activation of
the IGF axis also increases muscle mass [40], the lack of
discrimination of the BMI variable for fat and muscle body
compartments may account for its poor correlation with
IGF2 ICR methylation.
The lack of associations between IGF2/H19 ICR methy-
lation and visceral fat or abdominal circumference (a mar-
ker for central adiposity) are also interesting to note. We
speculate that the lack of association seen might be due to
the relative youth of our cohort where the early response
to obesogenic influences results in preferential fat depos-
ition in the protective subcutaneous compartment [41,42],
imparting a lesser metabolic risk than the visceral com-
partment [43]. At 17 years of age, DNA methylation at the
IGF2/H19 ICR does not appear to be associated with
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clusion can be drawn as to whether the altered DNA
methylation is a consequence or cause of the altered sub-
cutaneous adiposity in our study.
Based on the knowledge that suboptimal intrauterine
environments leading to fetal programming are asso-
ciated with epigenetic changes [14,15], we hypothesized
that birth anthropometry would be associated with
IGF2/H19 ICR methylation. Contrary to this, we did not
detect an association of DNA methylation with any birth
size parameters. This finding is not so unexpected given
that fetal programming caused by altered intrauterine
environment has been shown repeatedly to occur without
disturbance in birth size [15,44,45]. Sheep experiments
isolating the effect of maternal under- and over-nutrition
in the periconceptional period, show that weight at birth
is not affected [45], despite subsequent development of
increased obesity and adverse metabolic parameters. In
the Dutch Famine cohort, only modest differences in birth
weight of 50 to 100 g were observed for exposed indivi-
duals overall [46] and epigenetic differences were only
present in those of normal birth weight after being
exposed to periconceptional starvation [15]. Those with
exposure to starvation later in gestation did demonstrate
reduced birth weight, but in the absence of changes in
DNA methylation [15]. On a molecular level, epigenetic
marks may be particularly vulnerable during very early
development [47] a finding supported by experimental evi-
dence of altered H19 methylation and expression in
mouse 2 cell embryos cultured to the very early stage of
blastocysts [48]. In addition, there is evidence that intra-
uterine growth retardation may not be associated with epi-
genetic changes at IGF2 [49-51]. This suggests that birth
weight may be a poor surrogate for a suboptimal environ-
ment during pregnancy when testing for fetal program-
ming via DNA methylation mechanisms. It is likely that
the intrauterine effects that cause DNA methylation
changes in a modern, well-nourished population are subtle
and do not cause great birth weight changes.
In our study, head circumference (HC) at birth was
not correlated with IGF/H19 ICR DNA methylation at
17 years. However, between 1 and 10 years HC was
negatively correlated with IGF/H19 ICR DNA methyla-
tion (in all CpG units except for CpG 23). The key role
of the IGF axis and methylation of its related genes in
head size maintenance is evident; for example, IGF1-de-
ficient subjects treated with exogenous IGF1 show a
striking increase in head circumference [52]. Adult brain
size has been shown to relate positively to IGF2 DMR2
(exon 9) methylation and be negatively related to IGF/
H19 ICR (at the CTCF3 region 2kb from our ICR assay)
DNA methylation in DNA extracted from the cerebel-
lum [53,54]. Although the region within the ICR assayed
in the latter study did not overlap with our assay, thenegative direction of association was the same. Further,
dietary interventions aimed at modifying DNA methyla-
tion (periconceptional folate supplementation) have been
associated with both increases in IGF2 DMR DNA
methylation [28] and head size [55]. In-utero head cir-
cumference is genetically [56] and, possibly also, epigen-
etically controlled.
The reason that an association was detectable in in-
fancy/childhood, but not immediately post-delivery may
be due to compromise in the accuracy of HC measure-
ments by molding that inevitably occurs with a non-
breech delivery. In addition, maternal uterine constraint
may play a role, whereby both gain in size and stunting
only become apparent after a period of time outside the
limiting influences of the womb [57]. Differences might
also be due to variation in the mechanisms of IGF2/H19
imprinting between blood and brain [58]. Alternatively,
birth size may truly have no linear relationship with
IGF2/H19 methylation. This is plausible given that fetal
programming can occur without change in birth size
[45]. It is also possible that in our cohort, fetal program-
ming may have influenced DNA methylation at the
IGF2/H19 locus, specifically in utero, for which there is
prior evidence in relation to certain early life environ-
ments [28,29,59].
No conclusion can be drawn as to whether the altered
DNA methylation is a consequence or cause of the
altered head size in our study. The DNA methylation
was measured at a later age than some of the longitu-
dinal anthropometry measurements. Nevertheless, there
is evidence that imprinted domains, such as the studied
IGF2/H19 ICR (having been established either in germ
cells in the previous generation or somatic tissues in
utero), are relatively stable over time postnatally [60],
into late adulthood [61,62] and equivalent across tissues
in humans [60]. As further indirect confirmation we
have shown that Ollikainen et al.’s [18] measurements of
the same region at birth are comparable to measure-
ments at age 14 years in this study.
This is, to our knowledge, the first study to investigate
the association between DNA methylation and longitu-
dinal growth. Although RNA was not available from study
members, we suggest that, due to the previously demon-
strated association between IGF2/H19 DMR methylation,
expression and levels of IGF2 protein [63], this association
will extend to levels of IGF2 transcripts and protein. A
strength of the study is the large number of subjects and
the serial prospective anthropometry. However, a limita-
tion of the study is that DNA methylation has only been
measured at one time point at age 17. Although methyla-
tion levels in peripheral blood (as used in our study) ap-
pear very similar to those seen at birth in the same tissue
[18] and IGF2/H19 imprinting is likely to be stable over
time in adults [60,62], a greater understanding is required
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methylation in childhood and adolescence.
Further, the importance of tissue in which the DNA
methylation is measured needs to be considered, as we have
found that effects of intrauterine exposures can be different
and even opposite in different tissues (JMC, unpublished
data). DNA has been derived from peripheral blood sam-
ples in this study for ethical and practical reasons. To our
knowledge, no study has compared methylation in blood,
adipose and brain tissues, although altered DNA methyla-
tion has been observed with obesity in peripheral blood
[64]. Furthermore, the region we studied (H19 CTCF6
DMR) has shown minimal variation in methylation between
tissues, while IGF2 DMR showed greater variation [18].
Other limitations are the subset of the Raine cohort
used for this study, which is biased to higher BMI and
extremes of cortisol measurements. Although adjust-
ment for serum cortisol and adrenocorticotropic hor-
mone (ACTH) in the models did not alter the direction
or significance of our findings (data now shown), the sig-
nificance of our findings would be enhanced with further
analysis of the entire cohort and in other cohorts.
In a similar manner to genetic linkage, interaction be-
tween CpG sites needs to be resolved to clarify interpret-
ation of epigenetic studies [65,66]. The statistical challenge
of modeling potentially highly-correlated CpG sites raises
the issue of collinearity, whereby use of multiple regres-
sion to isolate the individual contribution of each CpG site
to the association under study becomes difficult. To over-
come this issue, we took two approaches. First, we per-
formed univariate regression, whereby each of the six CpG
units was investigated individually. This allowed identifica-
tion of individual CpG units potentially playing a greater
or lesser role in the phenotypes, but has the drawback of
multiple testing and the potential of for false positives.
The second complementary approach, principal compo-
nents analysis, minimized multiple testing, while reflecting
average methylation across all the six CpG units. Both
methods were applied to investigate the effect of IGF2
DMR methylation on the outcome of anthropometry at 17
years (Figure 2) and the outcome of head circumference
(Table 3). For anthropometry at 17 years, the principal
components analysis confirms the univariate results, indi-
cating a general association with methylation in the IGF2
DMR region studied. For head circumference, the associa-
tions with individual CpG units appear to be of differing
signs for different CpG units, indicating that any associ-
ation with methylation in the region studied is more likely
to be CpG unit specific.
Conclusions
In summary, this study shows that IGF2/H19 ICR DNA
methylation is associated with a particular pattern of fat
distribution in early adult life and with altered headcircumference throughout childhood. Our finding of a
greater DNA methylation with greater skin fold thick-
nesses is corroborated by the similar relationship we
observed with subcutaneous fat thickness measured by
direct ultrasound. It suggests that IGF2/H19 ICR DNA
methylation may be associated with altered trajectories
of body composition. The role of IGF2/H19 DNA
methylation on fetal programming on development of
obesity-related diseases needs clarification with longitu-
dinal measurements of DNA methylation paired with
serial growth measurements.
Methods
Ethics statement
Ethics approval was obtained from the relevant institutional
Human Ethics Committees (Princess Margaret Hospital).
Written informed consent was obtained at recruitment and
at each follow-up from the mother or legal guardian as well
as from the adolescent at 17 years.
Population
This study was undertaken on the West Australian Preg-
nancy (Raine) Study described elsewhere [67]. The Raine
study recruited 2,900 women in 1989 to 1990 who deliv-
ered 2,868 live births. Follow-up of the offspring has
been undertaken at 1, 2, 3, 5, 8, 10, 14 and 17 years. A
subset was selected at age 17 years (n = 315) for meas-
urement of IGF2/H19 ICR DNA methylation. This was a
pilot study for which samples were selected with pre-
ponderance for individuals with higher BMI and equally
across tertiles of salivary cortisol.
Anthropometry measurements at 17 years
At the 17-year follow-up, weight was measured using the
Wedderburn Chair Scales (to the nearest 100 g) and
height was measured by the Holtain Stadiometer (to the
nearest 0.1 cm). Body mass index (BMI) was calculated by
weight (kg)/height (m)2. Waist circumference was mea-
sured to the nearest cm. Head circumference measure-
ments during childhood were measured at 1, 2, 3, 5, 8 and
10 years of age.
Skin folds were measured with calipers (Holtain Tan-
ner/Whitehouse skin fold calliper, Holtain, Crosswell,
UK), taking a generous pinch of skin and subcutaneous
tissue with the body part in the relaxed state, taking care
not to include underlying muscle. The calipers were left
on for three seconds and skin fold thickness recorded to
the nearest 0.1 mm. The sub-scapular skin folds were
assessed from a vertical immediately beneath the apex of
the left scapula with the arm hanging by the child's side.
The supra-iliac skin fold was measured from a vertical
skin fold immediately above the left anterior superior
iliac spine. The abdominal skin fold was measured from
a vertical skin fold immediately to the left of the
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vertical skin fold on the posterior aspect of the upper
arm, halfway between the olecranon and the acromion
with the arm hanging by the individual's side.
Ultrasound measurement of fat thickness
Ultrasound (Siemens Antares, Mountain View, CA,
USA) was performed by trained ultrasonographers. Adi-
pose tissue thickness was measured using validated stan-
dardized criteria [68]. Visceral adipose tissue thickness
was measured as the distance between the anterior wall
of the aorta and the internal face of the rectus abdomens
muscle perpendicular to the aorta. Subcutaneous fat
thickness was measured as the thickness of the fat tissue
between the skin-fat interface and the linea alba. Care
was taken to avoid subcutaneous fat tissue compression.
A single specialist radiologist who was blinded to the
clinical and laboratory characteristics of the subjects
interpreted the ultrasound images.
Birth anthropometry
A midwife examined babies 24 to 72 hours after birth.
Length was measured with a Harpenden Neonatometer to
nearest 0.1 cm. Head circumference was measured to near-
est 0.1 cm and birth weight was measured to nearest gram.
DNA methylation
DNA extraction, bisulphite conversion and locus-
specific methylation analysis DNA was prepared from
whole blood cells by standard phenol:chloroform extrac-
tion and ethanol precipitation as described previously
[18]. A total of 500 ng to 1 μg genomic DNA was bisul-
phite converted using the MethylEasy Exceed Rapid
Bisulphite Modification Kit (Human Genetic Signatures,
North Ryde, NSW, Australia) and a region of the IGF2/
H19 ICR containing the sixth CTCF binding site
(chr11:2,020,978-2,021,293; NCBI Genome Browser as-
sembly 36) amplified as described previously [18]. DNA
methylation was measured using the MassARRAY Epi-
TYPER (SEQUENOM Inc., Herston, QLD, Australia).
This method relies on base-specific cleavage and mass
spectrometry to measure the level of methylation in
DNA fragments (referred to herein as units) containing
one or more CpGs [69]. To reduce methylation variabil-
ity introduced during PCR, at least two replicate amplifi-
cations were performed in all instances and data were
subjected to stringent cleaning steps as outlined previ-
ously [18]. In brief, CpG analytic units that failed to pro-
duce data for >30% of samples were discarded, and
samples with more than 30% missing data points within
an amplicon had all methylation values for that sample
set to missing. Finally, technical replicates showing ≥5%
absolute difference from the median value of a set of
technical replicates were set to missing and only sampleswith at least two successful technical replicates were
analyzed [18].
Statistical methods
Data were analyzed using SPSS version 19.0, Chicago,
IL, USA and STATA version 12 (StataCorp. 2011. Stata
Statistical Software: Release 12. College Station, TX,
USA: StataCorp LP.) Comparisons of participants at the
17-year follow-up with and without methylation were
performed using Chi-square for categorical variables and
t-tests for continuous variables, depending on whether
the assumption of normality was plausible.
All anthropometric measurements (birth weight and
height; head circumference at birth, 1, 2, 3, 5, 8 and
10 years; weight, height, BMI, waist circumference, skin-
fold and fat thicknesses at 17 years of age) were converted
to sex-specific z-scores. Because of the uncertain nature of
any relationship between DNA methylation and anthro-
pometry, whether general or involving specific CpG units
only, we first tested for a general association in this region.
To facilitate this investigation and, at the same time, to
reduce the number of regression coefficients being esti-
mated, a principal components analysis was performed
on the CpG unit variables to generate component scores
that were independent of each other. Two principal com-
ponents were constructed accounting for 49% and 24% of
the variance, respectively, and 73% of the total variance.
In our data, the first component represented the within-
subject mean of methylation across the CpG units, while
the second component represented the within-subject
standard deviation (SD) of methylation (correlation be-
tween the second component and within-subject SD was
0.98; eigenvectors for these two principal components are
given in Additional file 1: Table S4). Principal compo-
nents were converted to sex-specific z scores and then
used in a multivariable linear regression analysis to exam-
ine association with anthropometry at 17 years. Head cir-
cumference was measured at multiple time points,
necessitating a variance component adjustment using
STATA’s vce option, to account for the correlation be-
tween repeated measures within a subject. In addition to
assessment of a general association between DNA methy-
lation and anthropometry, an exploratory univariate linear
regression analysis looking at the effect of CpG unit DNA
methylation on each anthropometric measurement was
undertaken to explore the individual association of each
CpG unit with the anthropometric outcome. A subse-
quent multivariable model to separate the individual
contributions of the various CpG units was not viable due
to strong correlation between CpG units. Significance
criteria was set at alpha = 0.05. Due to the moderate
number of potentially positively-correlated tests, it was
deemed that adjustment for the increased risk of type I
error arising from multiple comparisons in the univariate
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Bonferroni adjustment are known to have low statistical
power and P-value distribution based methods such as the
False Discovery Rate rely on a substantial number inde-
pendent test, or clusters of tests, being performed [70].Additional file
Additional file 1: Table S1. Comparison of participants at 17-year
follow-up who did and did not have DNA methylation measured. Table
S2. Results of univariate regression of skinfold, anthropometric, fat and
birth measures on DNA methylation at age 17. Table S3. Multivariate
models for birth anthropometry. Table S4. Eigenvectors for first two
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